The first diagnostic procedures to detect prostate cancer have taken place in Dewsbury.

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Abstract: Automatic fusion of transrectal ultrasound (TRUS) and magnetic resonance (MR) images for targeted prostate biopsies has significantly enhanced the detection of aggressive cancers. However, ...

We received back the results of Tom's Prostate Biopsy and they did identify cancer in 3/15 core samples taken. The doctors indicated that it was an intermediate grade cancer with a Gleason score of 7.

At 3 years, transdermal estradiol demonstrated noninferior MFS compared with standard LHRH agonists. A large phase 3 randomized trial has demonstrated that transdermal estradiol (tE2) patches are ...

Subscribe Login Register Log out My Profile Subscriber Services Search PGe NEWSLETTERS PG STORE ARCHIVES PUBLIC NOTICES OBITUARIES JOBS CLASSIFIEDS EVENTS PETS ...

A REAL-WORLD comparative study from a Moroccan tertiary centre has found that transperineal (TP) prostate biopsy offers similar cancer detection rates to the traditional transrectal (TR) approach, ...

Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs. It’s often said that if you have your health, you have everything, and there ...

Metastasis-free survival at 3 years was 87.1% with transdermal estradiol versus 85.9% with LHRH agonists, meeting noninferiority (HR 0.96; upper one-sided 95% CI 1.11). A seamless adaptive phase 2/3 ...